BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 18832961)

  • 1. Practical application of therapeutic drug monitoring: a tale of two patients.
    Preskorn SH
    J Psychiatr Pract; 2008 Sep; 14(5):301-6. PubMed ID: 18832961
    [No Abstract]   [Full Text] [Related]  

  • 2. Lack of sertraline efficacy probably due to an interaction with carbamazepine.
    Khan A; Shad MU; Preskorn SH
    J Clin Psychiatry; 2000 Jul; 61(7):526-7. PubMed ID: 10937612
    [No Abstract]   [Full Text] [Related]  

  • 3. CYP2D6 inhibition in patients treated with sertraline.
    Sproule BA; Otton SV; Cheung SW; Zhong XH; Romach MK; Sellers EM
    J Clin Psychopharmacol; 1997 Apr; 17(2):102-6. PubMed ID: 10950472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spotlight on sertraline in the management of major depressive disorder in elderly patients.
    Muijsers RB; Plosker GL; Noble S
    CNS Drugs; 2002; 16(11):789-94. PubMed ID: 12383038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma risperidone concentrations during combined treatment with sertraline.
    Spina E; D'Arrigo C; Migliardi G; Morgante L; Zoccali R; Ancione M; Madia A
    Ther Drug Monit; 2004 Aug; 26(4):386-90. PubMed ID: 15257068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SSRI-antipsychotic combination in psychotic depression: sertraline pharmacokinetics in the presence of olanzapine, a brief report from the STOP-PD study.
    Davies SJ; Mulsant BH; Flint AJ; Meyers BS; Rothschild AJ; Whyte EM; Kirshner MM; Sorisio D; Pollock BG; Bies RR;
    Hum Psychopharmacol; 2016 May; 31(3):252-5. PubMed ID: 27060853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbamazepine for serotonin reuptake inhibitor nonresponder case of obsessive compulsive disorder.
    Aggarwal A; Jain M; Garg A; Jiloha RC
    Indian J Med Sci; 2009 Oct; 63(10):468-9. PubMed ID: 19901487
    [No Abstract]   [Full Text] [Related]  

  • 8. [Carbamazepine overdose following administration of sertraline: relation to serotonergic syndrome?].
    Vercueil L; Adriantseheno LM; Hirsch E
    Therapie; 1998; 53(5):502-4. PubMed ID: 9921045
    [No Abstract]   [Full Text] [Related]  

  • 9. Partial compliance as determined from plasma levels of sertraline and its metabolite in depressed patients in primary care.
    Reis M; Akerblad AC; Ekselius L; von Knorring L
    J Clin Psychopharmacol; 2010 Dec; 30(6):746-8. PubMed ID: 21057244
    [No Abstract]   [Full Text] [Related]  

  • 10. Psychotic depression, subcortical arteriosclerotic encephalopathy and holocaust-conditioned posttraumatic stress disorder.
    Kropp S; Schlimme J; Schneider U
    Aust N Z J Psychiatry; 2001 Feb; 35(1):129. PubMed ID: 11270447
    [No Abstract]   [Full Text] [Related]  

  • 11. Topiramate augmentation in a patient with obsessive-compulsive disorder.
    Van Ameringen M; Patterson B
    J Psychiatry Neurosci; 2015 Sep; 40(5):E31-2. PubMed ID: 26290064
    [No Abstract]   [Full Text] [Related]  

  • 12. A case of "double" depression under outpatient treatment conditions.
    Ros LT
    World J Biol Psychiatry; 2004 Jul; 5(3):161-3. PubMed ID: 15346541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum monitoring of antipsychotic drug levels during concomitant administration of sertraline and antipsychotic medication.
    Pierson K; Addington D; Addington J; Patten S
    Can J Psychiatry; 2006 Oct; 51(11):715-8. PubMed ID: 17121171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant reduction of sertraline plasma levels by carbamazepine and phenytoin.
    PihlsgÄrd M; Eliasson E
    Eur J Clin Pharmacol; 2002 Feb; 57(12):915-6. PubMed ID: 11936714
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of sertraline on depressive symptoms and attentional and executive functions in major depression.
    Constant EL; Adam S; Gillain B; Seron X; Bruyer R; Seghers A
    Depress Anxiety; 2005; 21(2):78-89. PubMed ID: 15884090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and acceptability of sertraline and citalopram in major depressive disorder: pragmatic randomized open-label comparison.
    Matreja PS; Badyal DK; Khosla P; Deswal RS
    Hum Psychopharmacol; 2007 Oct; 22(7):477-82. PubMed ID: 17647298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbamazepine hypersensitivity.
    Bellman B; Schachner LA; Pravder L; McFalls S; Shapiro B
    J Am Acad Child Adolesc Psychiatry; 1995 Nov; 34(11):1405-6. PubMed ID: 8543507
    [No Abstract]   [Full Text] [Related]  

  • 18. Sertraline versus venlafaxine XR in major depressive disorder.
    Lusicic A; Jagadheesan K
    J Clin Psychiatry; 2007 Oct; 68(10):1618-9; author reply 1619. PubMed ID: 17960983
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder.
    Spielmans GI
    JAMA; 2004 Jan; 291(1):41. PubMed ID: 14709570
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder.
    Solyom AE
    JAMA; 2004 Jan; 291(1):41-2; author reply 42. PubMed ID: 14709569
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.